- From Isolation to ‘Slaying’: Young Mother Reclaims Her Life After Fistula Surgery
- A Speculative Exploration of the CJC-1295 and Ipamorelin Peptide Blend
- Pick n Pay, CABS Unite in $260,000 Cancer Drive
- US Clarifies Type of Health Data Requested in Zimbabwe Talks
- Nedbank embarks on major Edith Opperman Maternity Clinic refurbishment
Africa’s Mpox Fight Faces Setback Without Urgent Delivery of 6 Million Vaccine Doses
By Michael Gwarisa As Mpox infections continue to surge in parts of Africa, health experts are sounding the alarm over a critical shortage of vaccines that threatens to derail the continent’s response efforts. Despite signs of a decline in cases in countries such as Uganda and Burundi, Africa’s stockpile of Mpox vaccines is rapidly depleting,
Read MoreAfrica CDC Confirms Mpox Vaccine Production to Start in 2025
By Michael Gwarisa The Director-General of the Africa Centre for Disease Control (Africa CDC), Dr. Jean Kaseya, told a media briefing that local production of the Mpox vaccine on the continent will commence this year, although he did not provide specific timelines. In 2024, Africa CDC partnered with Bavarian Nordic to enhance vaccine manufacturing capabilities
Read MoreZimbabwe Records 90 Days Without Mpox
By Michael Gwarisa Zimbabwe is among the few African countries that have not recorded any new Mpox cases in the past three months, a top official at the Africa Centres for Disease Control and Prevention (Africa CDC) has said. In October 2024, Zimbabwe reported its first cases of Mpox, two months after the Africa CDC
Read More#JUSTIN: Africa CDC Declares Mpox A Public Health Emergency of Continental Security
By Michael Gwarisa The Africa Centres for Disease Control and Prevention (Africa CDC) has officially declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017. This declaration, under Article 3, Paragraph F of the Africa CDC Statutes, empowers the
Read More